2,838
Views
1
CrossRef citations to date
0
Altmetric
Review

Berberine: a comprehensive Approach to combat human maladies

, , ORCID Icon, , , , ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 787-807 | Received 13 Jul 2022, Accepted 05 Feb 2023, Published online: 28 Feb 2023

References

  • Och, A.; Zalewski, D.; Komsta, Ł.; Kołodziej, P.; Kocki, J.; Bogucka-Kocka, A. Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine, and Extracts of Chelidonium Majus L. and Berberis Thunbergii DC. toward Hematopoietic Cancer Cell Lines. Toxins. 2019, 11(9), 485. DOI: 10.3390/toxins11090485.
  • Neag, M. A.; Mocan, A.; Echeverría, J.; Pop, R. M.; Bocsan, C. I.; Crişan, G.; Buzoianu, A. D. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front. Pharmacol. 2018, 9(9), 557. DOI: 10.3389/fphar.2018.00557.
  • Baldwin-Lien, B.; Wei, W.; Zhao, H.; Wang, A. Berberine Compared to Metformin Study. Sat. 2019, 1, 16.
  • Lu, Q.; Fu, Y.; Li, H.; Ebrahimnejad, M.; Kholghi, G.; Zarrindast, M.-R. Berberine and Its Derivatives Represent as the Promising Therapeutic Agents for Inflammatory Disorders. Pharmacol Rep. 2022, 74(1), 1–13. DOI: 10.1007/s43440-021-00339-8.
  • Cicero, A. F.; Baggioni, A. Berberine and Its Role in Chronic Disease Anti-inflammatory Nutraceuticals and Chronic Diseases; Springer International Publishing Switzerland, 2016; pp 27–45.
  • Fan, J.; Zhang, K.; Jin, Y.; Li, B.; Gao, S.; Zhu, J.; Cui, R. Pharmacological Effects of Berberine on Mood Disorders. J. Cellular Mol. Med. 2019, 23(1), 21–28. DOI: 10.1111/jcmm.13930.
  • Andola, H. C.; Gaira, K. S.; Rawal, R. S.; Rawat, M. S. M.; Bhatt, I. D. Habitat-dependent Variations in Berberine Content of Berberis Asiatica Roxb. Ex. DC. in Kumaon, Western Himalaya. Chem. Biodiversity. 2010, 7(2), 415–420. DOI: 10.1002/cbdv.200900041.
  • Srivastava, S. K.; Rai, V.; Srivastava, M.; Rawat, A. K. S.; Mehrotra, S. Estimation of Heavy Metals in Different Berberis Species and Its Market Samples. Environ. Monit. Assess. 2006, 116(1), 315–320. DOI: 10.1007/s10661-006-7395-x.
  • Singh, S. Quantitative Analysis of Berberine in Argemone Mexicana Linn(Papaveraceae) Using HPLC and HPTLC. Adv. Plant Sci. 2014, 27, 209–211.
  • Srivastava, S. K.; Singh Rawat, A. K.; Mehrotra, S. Pharmacognostic Evaluation of the Root of Berberis Asiatica. Pharm. Biol. 2004, 42(6), 467–473. DOI: 10.1080/13880200490886256.
  • Rajasekaran, A.; Pokhriyal, R.; Singh, Y. (2009). Quantitative Estimation of Berberine in Roots of Different Provenances of Berberis Aristata DC by HPLC and Study of Their Antifungal Properties. Pharmacognosy Magazine. 5(20), 355.
  • Verma, S.; Sharma, D. Berberine: A Pioneer Remedy for Various Ailments. Pharm. Innovation J. 2018, 7(10), 194–200.
  • Brown, C. O.; Tseng, P. Y.; Lin, I. Y.; Tsai, C. E.; Chen, C. K. Therapeutic Uses of Berberine Formulations, U.S Patent US20150320738 A1, 2016.
  • Liu, C. S.; Zheng, Y. R.; Zhang, Y. F.; Long, X. Y. Research Progress on Berberine with a Special Focus on Its Oral Bioavailability. Fitoterapia. 2016, 109, 274–282. DOI: 10.1016/j.fitote.2016.02.001.
  • Pan, C.; Guo, Q.; Lu, N. Role of Gut Microbiota in the Pharmacological Effects of Natural Products. Evid. Based Complement. Altern. Med. 2019, 2019, 2682748. DOI: 10.1155/2019/2682748.
  • de Oliveira, J. S.; Abdalla, F. H.; Dornelles, G. L.; Palma, T. V.; Signor, C.; da Silva Bernardi, J.; de Andrade, C. M.; Lenz, L. S.; de Oliveira, V. A.; Chitolina Schetinger, M. R. Neuroprotective Effects of Berberine on Recognition Memory Impairment, Oxidative Stress, and Damage to the Purinergic System in Rats Submitted to Intracerebroventricular Injection of Streptozotocin. Psychopharmacology. 2019, 236(2), 641–655. DOI: 10.1007/s00213-018-5090-6.
  • Pervez, S.; Saeed, M.; Ali, M. S.; Fatima, I.; Khan, H.; Ullah, I. Antimicrobial and Antioxidant Potential of Berberisinol, a New Flavone from Berberis Baluchistanica. Chem. Nat. Compd. 2019, 55(2), 247–251. DOI: 10.1007/s10600-019-02660-4.
  • Jiang, L.; Iwahashi, H. The Roles of radio-functional Natural Chemicals for the Development of Cancer Radiation Therapy. Reviews on Environmental Health. 2019, 34(1), 5–12. DOI: 10.1515/reveh-2018-0057.
  • Pirmoradi, Z.; Yadegari, M.; Moradi, A.; Khojasteh, F.; Mehrjerdi, F. Z. Effect of Berberine Chloride on Caspase-3 Dependent Apoptosis and Antioxidant Capacity in the Hippocampus of the Chronic Cerebral Hypoperfusion Rat Model. Iran. J. Basic Med. Sci. 2019, 22(2), 154. DOI: 10.22038/ijbms.2018.31225.7534.
  • Putta, S.; Qureshi, A. A.; Kilari, E. K. Berberine Attenuates the Acute Pancreatitis Induced by Dibutyltin Dichloride (DBTC) in Albino Wistar Rats. FASEB. J. 2019, 33(S1), 820–824. DOI: 10.1096/fasebj.2019.33.1_supplement.820.4.
  • Jia, Q.; Zhang, L.; Zhang, J.; Pei, F.; Zhu, S.; Sun, Q.; Duan, L. Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially. Biomed Res. Int. 2019, 2019, 4530203. DOI: 10.1155/2019/4530203.
  • Kumar, V.; Gupta, P.; Hassan, M. I. Mechanism and Implications of Traditional Chinese Medicine in Amyotrophic Lateral Sclerosis Therapy. J. Pro.and Pro. 2019, 10, 131–147.
  • Zhang, B.; Yue, R.; Chen, Y.; Yang, M.; Huang, X.; Shui, J.; Chin, J. Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus. Evid. Based Complement. Altern. Med. 2019, 2019, 2634898. DOI: 10.1155/2019/2634898.
  • Freag, M. S.; Torky, A. S.; Nasra, M. M.; Abdelmonsif, D. A.; Abdallah, O. Y. (2019). Liquid Crystalline Nanoreservoir Releasing a Highly skin-penetrating Berberine Oleate Complex for Psoriasis Management. Nanomedicine. 2019, 14(8), 931–954. DOI: 10.2217/nnm-2018-0345.
  • Ghareeb, D. A. Berberine Is multi-targets Therapeutic Weapon; Medical Biotechnology Resolves the Mystery. J. Alexandria Sci. 2019, 1, 2.
  • Kumar, A.; Dhull, D. K.; Dhull, D. K.; Dhull, D. K.; Dhull, D. K.; Dhull, D. K. Current Knowledge and Pharmacological Profile of Berberine: An Update. Eur. J. Pharmacol. 2015, 761(761), 288–297. DOI: 10.1016/j.ejphar.2015.05.068.
  • Ye, M.; Fu, S.; Pi, R.; He, F. Neuropharmacological and Pharmacokinetic Properties of Berberine: A Review of Recent Research. J. Pharm. Pharmacol. 2009, 61(7), 831–837. DOI: 10.1211/jpp.61.07.0001.
  • Tan, X. S.; Ma, J. Y.; Feng, R.; Ma, C.; Chen, W. J.; Sun, Y. P.; Jiang, J. D.; Huang, M.; He, C.-Y.; Shou, J.-W. (2013). Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats. PloS one. 2013, 8(10), e77969. DOI: 10.1371/journal.pone.0077969.
  • Xiong, R. G.; Huang, S. Y.; Wu, S. X.; Zhou, D. D.; Yang, Z. J.; Saimaiti, A.; Zhao, C. N.; Shang, A.; Zhang, Y. J.; Gan, R. Y., et al. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Molecules. 2022, 27(14), 4523.
  • Song, J.; Lin, C.; Yang, X.; Xie, Y.; Hu, P.; Li, H.; Hu, W.; Hu, H. Mitochondrial Targeting Nanodrugs self-assembled from 9-O-octadecyl Substituted Berberine Derivative for Cancer Treatment by Inducing Mitochondrial Apoptosis Pathways. J. Controlled Release. 2019, 294, 27–42. DOI: 10.1016/j.jconrel.2018.11.014.
  • Hassanein, E. H.; Shalkami, A. G. S.; Khalaf, M. M.; Mohamed, W. R.; Hemeida, R. A. The Impact of Keap1/Nrf2, P38MAPK/NF-κB and Bax/Bcl2/caspase-3 Signaling Pathways in the Protective Effects of Berberine against methotrexate-induced Nephrotoxicity. Biomed. Pharmacother. 2019, 109, 47–56. DOI: 10.1016/j.biopha.2018.10.088.
  • Ri, M. H.; Ma, J.; Jin, X. Development of Natural Products for anti-PD-1/PD-L1 Immunotherapy against Cancer. J. Ethnopharmacol. 2021, 281, 114370. DOI: 10.1016/j.jep.2021.114370.
  • Jabbarzadeh Kaboli, P.; Leong, M. P. Y.; Ismail, P.; Ling, K. H. Antitumor Effects of Berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 Breast Cancer Cells Using Molecular Modelling and in Vitro Study. Pharmacol Rep. 2019, 71(1), 13–23. DOI: 10.1016/j.pharep.2018.07.005.
  • Yao, Z.; Wan, Y.; Li, B.; Zhai, C.; Yao, F.; Kang, Y.; Lin, D. Berberine Induces Mitochondrial‑mediated Apoptosis and Protective Autophagy in Human Malignant Pleural Mesothelioma NCI‑H2452 Cells. Oncol. Rep. 2018, 40(6), 3603–3610. DOI: 10.3892/or.2018.6757.
  • Abrams, S. L.; Follo, M. Y.; Steelman, L. S.; Lertpiriyapong, K.; Cocco, L.; Ratti, S.; McCubrey, J. A.; Candido, S.; Libra, M.; Murata, R. M. Abilities of Berberine and Chemically Modified Berberines to Inhibit Proliferation of Pancreatic Cancer Cells. Adv. Biol. Reg. 2019, 71, 172–182. DOI: 10.1016/j.jbior.2018.10.003.
  • Li, X. D.; Wang, Z.; Wang, X. R.; Shao, D.; Zhang, X.; Li, L.; Dong, W. F.; Chang, Z.-M.; Dong, W.-F. Berberine-loaded Janus Gold Mesoporous Silica Nanocarriers for chemo/radio/photothermal Therapy of Liver Cancer and radiation-induced Injury Inhibition. Int. J. Nanomed. 2019, 14, 3967. DOI: 10.2147/IJN.S206044.
  • Shinji, S.; Nakamura, S.; Nihashi, Y.; Umezawa, K.; Takaya, T. Berberine and Palmatine Inhibit the Growth of Human Rhabdomyosarcoma Cells. Biosci., Biotechnol., Biochem. 2020, 84(1), 63–75. DOI: 10.1080/09168451.2019.1659714.
  • Huang, C.; Wang, X. L.; Qi, F. F.; Pang, Z. L. Berberine Inhibits epithelial-mesenchymal Transition and Promotes Apoptosis of tumour-associated fibroblast-induced Colonic Epithelial Cells through Regulation of TGF-β Signalling. J. Cell Commun. Signaling. 2020, 14(1), 53–66. DOI: 10.1007/s12079-019-00525-7.
  • Liu, M.; Gao, L.; Zhang, N. Berberine Reduces Neuroglia Activation and Inflammation in streptozotocin-induced Diabetic Mice. Inter. J. Immuno. Pharmacol. 2019, 33, 2058738419866379. DOI: 10.1177/2058738419866379.
  • Kou, J. Y.; Li, Y.; Zhong, Z. Y.; Jiang, Y. Q.; Li, X. S.; Han, X. B.; Yang, L. M.; Tian, Y.; Yang, L. M. Berberine-sonodynamic Therapy Induces Autophagy and Lipid Unloading in Macrophage. Cell Death & Disease. 2018, 8(1), e2558–e2558. DOI: 10.1038/cddis.2016.354.
  • Maiti, P.; Plemmons, A.; Dunbar, G. L. Combination Treatment of Berberine and Solid Lipid Curcumin Particles Increased Cell Death and Inhibited PI3K/Akt/mTOR Pathway of Human Cultured Glioblastoma Cells More Effectively than Did Individual Treatments. PloS one. 2019, 14(12), e0225660. DOI: 10.1371/journal.pone.0225660.
  • Kim, S.; You, D.; Jeong, Y.; Yu, J.; Kim, S. W.; Nam, S. J.; Lee, J. E. Berberine down-regulates IL-8 Expression through Inhibition of the EGFR/MEK/ERK Pathway in triple-negative Breast Cancer Cells. Phytomedicine. 2018, 50, 43–49. DOI: 10.1016/j.phymed.2018.08.004.
  • Dai, W.; Mu, L.; Cui, Y.; Li, Y.; Chen, P.; Xie, H.; Wang, X. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long non-coding RNA (Lncrna) Cancer Susceptibility Candidate 2 (CASC2)/AU-binding Factor 1 (AUF1)/B-cell CLL/lymphoma 2 (Bcl-2) Axis. Med. Sci. Monitor: Inter. Med. J. Experi. and Clinical Res. 2019, 25, 730. DOI: 10.12659/MSM.912082.
  • Nishi, K.; Suzuki, K.; Sawamoto, J.; Tokizawa, Y.; Iwase, Y.; Yumita, N.; Ikeda, T. Inhibition of Fatty Acid Synthesis Induces Apoptosis of Human Pancreatic Cancer Cells. Anticancer Res. 2016, 36(9), 4655–4660. DOI: 10.21873/anticanres.11016.
  • Yue, X.; Zhao, Y.; Xu, Y.; Zheng, M.; Feng, Z.; Hu, W. Mutant p53 in Cancer: Accumulation, gain-of-function, and Therapy. J. Mol. Biol. 2017, 429(11), 1595–1606. DOI: 10.1016/j.jmb.2017.03.030.
  • Levine, A. J.; Hu, W.; Feng, Z. The P53 Pathway: What Questions Remain to Be Explored? Cell Death & Different. 2006, 13(6), 1027–1036. DOI: 10.1038/sj.cdd.4401910.
  • Muller, P. A.; Vousden, K. H. Mutant p53 in Cancer: New Functions and Therapeutic Opportunities. Cancer Cell. 2014, 25(3), 304–317. DOI: 10.1016/j.ccr.2014.01.021.
  • Freed-Pastor, W. A.; Prives, C. Mutant p53: One Name, Many Proteins. Genes Dev. 2012, 26(12), 1268–1286. DOI: 10.1101/gad.190678.112.
  • Liu, Z.; Chen, Y.; Gao, H.; Xu, W.; Zhang, C.; Lai, J.; … Huang, H. Berberine Inhibits Cell Proliferation by Interfering with wild-type and Mutant P53 in Human Glioma Cells. OncoTargets Ther. 2020, 13, 12151. DOI: 10.2147/OTT.S279002.
  • Qu, H.; Song, X.; Song, Z.; Jiang, X.; Gao, X.; Bai, L.; Yao, Z.; Na, L.; Yao, Z. Berberine Reduces Temozolomide Resistance by Inducing Autophagy via the ERK1/2 Signaling Pathway in Glioblastoma. Can. Cell Inter. 2020, 20(1), 1–13. DOI: 10.1186/s12935-020-01693-y.
  • Samadi, P.; Sarvarian, P.; Gholipour, E.; Asenjan, K. S.; Aghebati-Maleki, L.; Motavalli, R.; Yousefi, M.; Yousefi, M. Berberine: A Novel Therapeutic Strategy for Cancer. IUBMB Life. 2020, 72(10), 2065–2079. DOI: 10.1002/iub.2350.
  • Paul, M.; Hemshekhar, M.; Kemparaju, K.; Girish, K. S. Berberine Mitigates High glucose-potentiated Platelet Aggregation and Apoptosis by Modulating Aldose Reductase and NADPH Oxidase Activity. Free Radical Biol. Med. 2019, 130, 196–205. DOI: 10.1016/j.freeradbiomed.2018.10.453.
  • Wang, Y.; Gong, W.; Lv, S.; Qu, H.; He, Y. Berberine Improves Insulin Resistance in Adipocyte Models by Regulating the Methylation of hypoxia-inducible factor-3α. Biosci. Rep. 2019, 39(10), 10. DOI: 10.1042/BSR20192059.
  • Mi, J.; He, W.; Lv, J.; Zhuang, K.; Huang, H.; Quan, S. Effect of Berberine on the HPA-axis Pathway and Skeletal Muscle GLUT4 in Type 2 Diabetes Mellitus Rats. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2019, 12, 1717. DOI: 10.2147/DMSO.S211188.
  • Zhao, L.; Liu, S.; Wang, M.; Zhi, M.; Geng, X.; Hou, C.; … Zhao, D. Berberine Restored Nitrergic and Adrenergic Function in Mesenteric and Iliac Arteries from streptozotocin-induced Diabetic Rats. J. Ethnopharmacol. 2019, 244, 112140. DOI: 10.1016/j.jep.2019.112140.
  • Ni, W. J.; Zhou, H.; Ding, H. H.; Tang, L. Q. Berberine Ameliorates Renal Impairment and Inhibits Podocyte Dysfunction by Targeting the Phosphatidylinositol 3-kinase–protein Kinase B Pathway in Diabetic Rats. J Diabetes Invest. 2020, 11(2), 297–306. DOI: 10.1111/jdi.13119.
  • Qin, X.; Zhao, Y.; Gong, J.; Huang, W.; Su, H.; Yuan, F.; … Lu, F. Berberine Protects Glomerular Podocytes via Inhibiting Drp1-mediated Mitochondrial Fission and Dysfunction. Theranostics. 2019, 9(6), 1698. DOI: 10.7150/thno.30640.
  • Rezaeiamiri, E.; Bahramsoltani, R.; Rahimi, R. Plant-derived Natural Agents as Dietary Supplements for the Regulation of Glycosylated Hemoglobin: A Review of Clinical Trials. Clin. Nutr. 2020, 39(2), 331–342. DOI: 10.1016/j.clnu.2019.02.006.
  • Pang, B.; Zhao, L. H.; Zhou, Q.; Zhao, T. Y.; Wang, H.; Gu, C. J.; Tong, X. L. Application of Berberine on Treating Type 2 Diabetes Mellitus. Int. J. Endocrinol. 2015, 2015(2015), 1–12. DOI: 10.1155/2015/905749.
  • Yin, S.; Bai, W.; Li, P.; Jian, X.; Shan, T.; Tang, Z.; Guo, T.; Ping, S.; Li, Q.; Miao, Z. Berberine Suppresses the Ectopic Expression of miR-133a in Endothelial Cells to Improve Vascular Dementia in Diabetic Rats. Clini. Experi. Hyper. 2019, 41(8), 708–716. DOI: 10.1080/10641963.2018.1545846.
  • Simioni, C.; Zauli, G.; Martelli, A. M.; Vitale, M.; Sacchetti, G.; Gonelli, A.; Neri, L. M. Oxidative Stress: Role of Physical Exercise and Antioxidant Nutraceuticals in Adulthood and Aging. Oncotarget. 2018, 9(24), 17181. DOI: 10.18632/oncotarget.24729.
  • Kazaz, I. O.; Mentese, A.; Demir, S.; Kerimoglu, G.; Colak, F.; Bodur, A.; Alver, A.; Kutlu, O.; Turedi, S. Berberine Inhibits the ischemia-reperfusion Induced Testicular Injury through Decreasing Oxidative Stress. Am. J. Emergency Med. 2020, 38(1), 33–37. DOI: 10.1016/j.ajem.2019.04.001.
  • Ahmed, T.; Nabavi, S. F.; Nabavi, S. F.; Nabavi, S. F.; Nabavi, S. M.; Nabavi, S. M. Berberine and Neurodegeneration: A Review of Literature. Pharmacol Rep. 2015, 67(5), 970–979. DOI: 10.1016/j.pharep.2015.03.002.
  • Verma, S. K.; Thareja, S. An Overview on Chemistry of Natural Aldose Reductase Inhibitors for the Management of Diabetic Complications. Studi. Nat. Prod. Chem. 2020, 65, 381–429.
  • Lin, J.; Cai, Q.; Liang, B.; Wu, L.; Zhuang, Y.; He, Y.; Lin, W. Berberine, a Traditional Chinese Medicine, Reduces Inflammation in Adipose Tissue, Polarizes M2 Macrophages, and Increases Energy Expenditure in Mice Fed a High-Fat Diet. Med. Sci. Monitor: Inter. Med. J. Experi. and Clinical Res. 2019, 25, 87. DOI: 10.12659/MSM.911849.
  • Cazzaniga, M.; Bonanni, B. Relationship between Metabolic Disorders and Breast Cancer Incidence and Outcomes. Is There a Preventive and Therapeutic Role for Berberine? Anticancer Res. 2018, 38(8), 4393–4402. DOI: 10.21873/anticanres.12741.
  • Li, C.; Guan, X. M.; Wang, R. Y.; Xie, Y. S.; Zhou, H.; Ni, W. J.; Tang, L. Q. Berberine Mitigates High glucose-induced Podocyte Apoptosis by Modulating Autophagy via the mTOR/P70S6K/4EBP1 Pathway. Life Sci. 2020, 243, 117277. DOI: 10.1016/j.lfs.2020.117277.
  • Wang, H.; Zhu, C.; Ying, Y.; Luo, L.; Huang, D.; Luo, Z. Metformin and Berberine, Two Versatile Drugs in Treatment of Common Metabolic Diseases. Oncotarget. 2018, 9(11), 10135. DOI: 10.18632/oncotarget.20807.
  • Pirillo, A.; Catapano, A. L. Berberine, a Plant Alkaloid with lipid-and glucose-lowering Properties: From in Vitro Evidence to Clinical Studies. Atherosclerosis. 2015, 243(2), 449–461. DOI: 10.1016/j.atherosclerosis.2015.09.032.
  • Feng, X.; Sureda, A.; Jafari, S.; Memariani, Z.; Tewari, D.; Annunziata, G.; Shen, A. Z.; Hassan, S. T. S.; Šmejkal, K.; Malaník, M. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics. 2019, 9(7), 1923. DOI: 10.7150/thno.30787.
  • Rivellese, A. A.; Ciciola, P.; Costabile, G.; Vetrani, C.; Vitale, M. The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease. High Blood Pressure & Cardiovascular Prevention. 2019, 26(2), 101–111. DOI: 10.1007/s40292-019-00309-5.
  • Hadi, A.; Arab, A.; Ghaedi, E.; Rafie, N.; Miraghajani, M.; Kafeshani, M. Barberry (Berberis Vulgaris L.) Is A Safe Approach for Management of Lipid Parameters: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Complementary Ther. Med. 2019, 43, 117–124. DOI: 10.1016/j.ctim.2019.01.017.
  • Kaya, S. T.; Bozdogan, O.; Ozarslan, T. O.; Taskin, E.; Eksioglu, D.; Erim, F.; Yasar, S.; Yasar, S. The Protection of Resveratrol and Its Combination with Glibenclamide, but Not Berberine on the Diabetic Hearts against reperfusion-induced Arrhythmias: The Role of Myocardial K ATP Channel. Arch. Physiol. Biochem. 2019, 125(2), 114–121. DOI: 10.1080/13813455.2018.1440409.
  • Zhang, X.; Guan, T.; Yang, B.; Chi, Z.; Wan, Q.; Gu, H. F. Protective Effect of Berberine on High Glucose and hypoxia-induced Apoptosis via the Modulation of HIF-1α in Renal Tubular Epithelial Cells. Am. J. Transl. Res. 2019, 11(2), 669.
  • Fogacci, F.; Grassi, D.; Rizzo, M.; Cicero, A. F. Metabolic Effect of berberine–silymarin Association: A Meta-analysis of Randomized, Double-blind, Placebo-controlled Clinical Trials. Phytotherapy Res. 2019, 33(4), 862–870. DOI: 10.1002/ptr.6282.
  • Liu, L.; Liu, J.; Huang, Z.; Yu, X.; Zhang, X.; Dou, D.; Huang, Y. Berberine Improves Endothelial Function by Inhibiting Endoplasmic Reticulum Stress in the Carotid Arteries of Spontaneously Hypertensive Rats. Biochem. Biophys. Res. Commun. 2015, 458(4), 796–801.
  • Xiao, M.; Men, L. N.; Xu, M. G.; Wang, G. B.; Lv, H. T.; Liu, C. Berberine Protects Endothelial Progenitor Cell from Damage of TNF-α via the PI3K/AKT/eNOS Signaling Pathway. Eur. J. Pharmacol. 2014, 743, 11–16. DOI: 10.1016/j.ejphar.2014.09.024.
  • Chang, W.; Li, K.; Guan, F.; Yao, F.; Yu, Y.; Zhang, M.; … Chen, L. Berberine Pretreatment Confers Cardioprotection against ischemia–reperfusion Injury in a Rat Model of Type 2 Diabetes. Journal of Cardiovascular Pharmacology and Therapeutics. 2016, 21(5), 486–494. DOI: 10.1177/1074248415627873.
  • Zaha, V. G.; Qi, D.; Su, K. N.; Palmeri, M.; Lee, H. Y.; Hu, X.; Young, L. H.; Shulman, G. I.; Rabinovitch, P. S.; Russell, R. R. AMPK Is Critical for Mitochondrial Function during Reperfusion after Myocardial Ischemia. J. Mol. Cell. Cardiol. 2016, 91, 104–113. DOI: 10.1016/j.yjmcc.2015.12.032.
  • Park, D. W.; Jiang, S.; Liu, Y.; Siegal, G. P.; Inoki, K.; Abraham, E.; Zmijewski, J. W. GSK3β-Dependent Inhibition of AMPK Potentiates Activation of Neutrophils and Macrophages and Enhances Severity of Acute Lung Injury. Am. J. Physiol. 2014, 307(10), L735–L745.
  • Wang, Y.; Zidichouski, J. A. Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis. Cholesterol. 2018, 2018, 1–17. DOI: 10.1155/2018/7173920.
  • Mohammadian Haftcheshmeh, S.; Momtazi-Borojeni, A. A. Berberine as A Promising Natural Compound for the Treatment of Periodontal Disease: A Focus on Anti-inflammatory Properties. J. Cellular Mol. Med. 2021, 25(24), 11333–11337. DOI: 10.1111/jcmm.17019.
  • Sadraie, S.; Kiasalari, Z.; Razavian, M.; Azimi, S.; Sedighnejad, L.; Afshin-Majd, S.; Roghani, M.; Roghani, M. Berberine Ameliorates lipopolysaccharide-induced Learning and Memory Deficit in the Rat: Insights into Underlying Molecular Mechanisms. Metabolic Brain Disease. 2019, 34(1), 245–255. DOI: 10.1007/s11011-018-0349-5.
  • Vita, A. A.; Pullen, N. A. The Influence of Berberine on co-stimulatory Molecule Expression and T Cell Activation. Am. Assoc. Immnol. 2018, 171–11. DOI: 10.4049/jimmunol.200.Supp.175.11.
  • Sun, S.; Zhang, X.; Xu, M.; Zhang, F.; Tian, F.; Cui, J.; Xia, Y.; Liang, C.; Zhou, S.; Wei, H. Berberine Downregulates CDC6 and Inhibits Proliferation via Targeting JAK-STAT3 Signaling in Keratinocytes. Cell Death & Disease. 2019, 10(4), 274. DOI: 10.1038/s41419-019-1510-8.
  • Zaidi, T. S.; Kausar, R.; Malik, M.; Sarfraz, J.; Shafiq, A.; Chiragh, S. Comparison of Berberine and Dexamethasone on Blood and Bronchial Inflammatory Cells of Ovalbumin Sensitized Guinea Pigs. Esculapio202. 2021, 17(1), 34–38. DOI: 10.51273/esc21.251717.
  • Xu, Z.; Feng, W.; Shen, Q.; Yu, N.; Yu, K.; Wang, S.; Guo, Y.; Shioda, S.; Guo, Y. Rhizoma Coptidis and Berberine as a Natural Drug to Combat Aging and aging-related Diseases via anti-oxidation and AMPK Activation. Aging and Disease. 2017, 8(6), 760. DOI: 10.14336/AD.2016.0620.
  • McCubrey, J. A.; Lertpiriyapong, K.; Steelman, L. S.; Abrams, S. L.; Cocco, L.; Ratti, S.; Martelli, A. M.; Candido, S.; Libra, M.; Montalto, G. Regulation of GSK-3 Activity by Curcumin, Berberine and Resveratrol: Potential Effects on Multiple Diseases. Adv. Biol. Reg. 2017, 65, 77–88. DOI: 10.1016/j.jbior.2017.05.005.
  • Martel, J.; Ojcius, D. M.; Ko, Y. F.; Chang, C. J.; Young, J. D. Antiaging Effects of Bioactive Molecules Isolated from Plants and Fungi. Med. Res. Rev. 2019, 39(5), 1515–1552. DOI: 10.1002/med.21559.
  • Yu, Y.; Zhao, Y.; Teng, F.; Li, J.; Guan, Y.; Xu, J.; Chen, L.; Guan, F.; Zhang, M.; Chen, L. Berberine Improves Cognitive Deficiency and Muscular Dysfunction via Activation of the AMPK/SIRT1/PGC-1a Pathway in Skeletal Muscle from Naturally Aging Rats. j. nutr. health aging. 2018, 22(6), 710–717. DOI: 10.1007/s12603-018-1015-7.
  • Sharma, R.; Padwad, Y. In Search of Nutritional Anti-Aging Targets: TOR Inhibitors, SASP Modulators, and BCL-2 Family Suppressors. Nutrition. 2019, 65, 33–38. DOI: 10.1016/j.nut.2019.01.020.
  • Cai, Z.; Wang, C.; Yang, W. Role of Berberine in Alzheimer’s Disease. Neuropsychiatr Dis Treat. 2016, 12, 2509. DOI: 10.2147/NDT.S114846.
  • El-Horany, H. E.-S.; Gaballah, H. H.; Helal, D. S. Berberine Ameliorates Renal Injury in a Rat Model of D-galactose-induced Aging through a PTEN/Akt-dependent Mechanism. Arch. Physiol. Biochem. 2018, 126(2), 1–9.
  • Shal, B.; Ding, W.; Ali, H.; Kim, Y. S.; Khan, S. Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer’s Disease. Front. Pharmacol. 2018, 9, 548. DOI: 10.3389/fphar.2018.00548.
  • Asai, M.; Iwata, N.; Yoshikawa, A.; Aizaki, Y.; Ishiura, S.; Saido, T. C.; Maruyama, K. Berberine Alters the Processing of Alzheimer’s Amyloid Precursor Protein to Decrease Abeta Secretion. Biochem. Biophys. Res. Commun. 2007, 352(2), 498–502. DOI: 10.1016/j.bbrc.2006.11.043.
  • Zhu, F.; Wu, F.; Ma, Y.; Liu, G.; Li, Z.; Sun, Y. A.; Pei, Z. Decrease in the Production of beta-amyloid by Berberine Inhibition of the Expression of beta-secretase in HEK293 Cells. BMC neuro. 2011, 12(1), 1–8. DOI: 10.1186/1471-2202-12-125.
  • Zhang, H.; Zhao, C.; Cao, G.; Guo, L.; Zhang, S.; Liang, Y.; Qin, C.; Su, P.; Li, H.; Zhang, W. Berberine Modulates amyloid-β Peptide Generation by Activating AMP-activated Protein Kinase. Neuropharmacology. 2017, 125, 408–417. DOI: 10.1016/j.neuropharm.2017.08.013.
  • Panahi, N.; Mahmoudian, M.; Mortazavi, P.; Hashjin, G. S. Effects of Berberine on β-secretase Activity in a Rabbit Model of Alzheimer’s Disease. Arch. Med. Sci. 2013, 9(1), 146–150. DOI: 10.5114/aoms.2013.33354.
  • Haghani, M.; Shabani, M.; Tondar, M. The Therapeutic Potential of Berberine against the Altered Intrinsic Properties of the CA1 Neurons Induced by Aβ Neurotoxicity. Eur. J. Pharmacol. 2015, 758, 82–88. DOI: 10.1016/j.ejphar.2015.03.016.
  • Durairajan, S. S.; Liu, L. F.; Lu, J. H.; Chen, L. L.; Yuan, Q.; Chung, S. K.; Huang, L.; Li, X. S.; Huang, J. D.; Li, M. Berberine Ameliorates β-amyloid Pathology, Gliosis, and Cognitive Impairment in an Alzheimer’s Disease Transgenic Mouse Model. Neurobiol. Aging. 2012, 33(12), 2903–2919. DOI: 10.1016/j.neurobiolaging.2012.02.016.
  • Kim, M.; Cho, K. H.; Shin, M. S.; Lee, J. M.; Cho, H. S.; Kim, C. J.; Shin, D. H.; Yang, H. J. Berberine Prevents Nigrostriatal Dopaminergic Neuronal Loss and Suppresses Hippocampal Apoptosis in Mice with Parkinson’s Disease. Int. J. Mol. Med. 2014, 33(4), 870–878. DOI: 10.3892/ijmm.2014.1656.
  • Bae, J.; Lee, D.; Kim, Y. K.; Gil, M.; Lee, J. Y.; Lee, K. J. Berberine Protects 6-hydroxydopamine-induced Human Dopaminergic Neuronal Cell Death through the Induction of Heme Oxygenase-1. Mol. Cells. 2013, 35(2), 151–157. DOI: 10.1007/s10059-013-2298-5.
  • Shin, K. S.; Choi, H. S.; Zhao, T. T.; Suh, K. H.; Kwon, I. H.; Choi, S. O.; Lee, M. K. Neurotoxic Effects of Berberine on long-term L-DOPA Administration in 6-hydroxydopamine-lesioned Rat Model of Parkinson’s Disease. Arch. Pharmacal Res. 2013, 36(6), 759–767. DOI: 10.1007/s12272-013-0051-4.
  • Kwon, I. H.; Choi, H. S.; Shin, K. S.; Lee, B. K.; Lee, C. K.; Hwang, B. Y.; Lim, S. C.; Lee, M. K. Effects of Berberine on 6-hydroxydopamine-induced Neurotoxicity in PC12 Cells and a Rat Model of Parkinson’s Disease. Neurosci. Lett. 2010, 486(1), 29–33. DOI: 10.1016/j.neulet.2010.09.038.
  • Fan, X.; Wang, J.; Hou, J.; Lin, C.; Bensoussan, A.; Chang, D.; Liu, J.; Wang, B. Bensoussan A., Chang D., Liu J., Wang B. Berberine Alleviates ox-LDL Induced Inflammatory Factors by up-regulation of Autophagy via AMPK/mTOR Signaling Pathway. J. Transl. Med. 2015, 13(1), 92. DOI: 10.1186/s12967-015-0450-z.
  • Kou, J. Y.; Li, Y.; Zhong, Z. Y.; Jiang, Y. Q.; Li, X. S.; Han, X. B.; Liu, Z. N.; Tian, Y.; Yang, L. M. Berberine-sonodynamic Therapy Induces Autophagy and Lipid Unloading in Macrophage. Cell Death Dis. 2017, e8(1), 2558.
  • Zhou, H.; Feng, L.; Xu, F.; Sun, Y.; Ma, Y.; Zhang, X.; Liu, H.; Xu, G.; Wu, X.; Shen, Y., et al. Berberine Inhibits palmitate-induced NLRP3 Inflammasome Activation by Triggering Autophagy in Macrophages: A New Mechanism Linking Berberine to Insulin Resistance Improvement. Biomed. Pharmacother. 2017, 89, 864–874. DOI: 10.1016/j.biopha.2017.03.003.
  • Chitra, P.; Saiprasad, G.; Manikandan, R.; Sudhandiran, G. Berberine Inhibits Smad and non-Smad Signaling Cascades and Enhances Autophagy against Pulmonary Fibrosis. J. Mol. Med. 2015, 93(9), 1015–1031. DOI: 10.1007/s00109-015-1283-1.
  • Peng, P. L.; Kuo, W. H.; Tseng, H. C.; Chou, F. P. Synergistic tumor-killing Effect of Radiation and Berberine Combined Treatment in Lung Cancer: The Contribution of Autophagic Cell Death. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70(2), 529–542.
  • Lee, K. H.; Lo, H. L.; Tang, W. C.; Hsiao, H. H.; Yang, P. M. A Gene Expression signature-based Approach Reveals the Mechanisms of Action of the Chinese Herbal Medicine Berberine. Sci. Rep. 2014, 4(1), 6394. DOI: 10.1038/srep06394.
  • Halicka, H. D.; Garcia, J.; Li, J.; Zhao, H.; Darzynkiewicz, Z. Synergy of 2-deoxy-D-glucose Combined with Berberine in Inducing the lysosome/autophagy and Transglutaminase activation-facilitated Apoptosis. Apoptosis. 2017, 22(2), 229–238. DOI: 10.1007/s10495-016-1315-5.
  • Chen, M.; Shen, H.; Zhu, L.; Yang, H.; Ye, P.; Liu, P.; , and Chen, S. Berberine Attenuates Hypoxia-induced Pulmonary Arterial Hypertension via Bone Morphogenetic Protein and Transforming Growth factor-β Signaling. J. Cell. Physiol. 2019, 234(10), 17482–17493.
  • Luo, J.; Gu, Y.; Liu, P.; Jiang, X.; Yu, W.; Ye, P.; Chao, Y.; Yang, H.; Zhu, L.; Zhou, L. Berberine Attenuates Pulmonary Arterial Hypertension via Protein Phosphatase 2A Signaling Pathway Both in Vivo and in Vitro. J. Cell. Physiol. 2018, 233(12), 9750–9762. DOI: 10.1002/jcp.26940.
  • Tian, H.; Kang, Y.-M.; Gao, H.-L.; Shi, X.-L.; Fu, L.-Y.; Li, Y.; Jia, X.-Y.; Liu, K.-L.; Qi, J.; Li, H.-B. Chronic Infusion of Berberine into the Hypothalamic Paraventricular Nucleus Attenuates Hypertension and Sympathoexcitation via the ROS/Erk1/2/iNOS Pathway. Phytomedicine. 2019, 52, 216–224. DOI: 10.1016/j.phymed.2018.09.206.
  • Akhzari, M.; Shafiee, S. M.; Rashno, S.; Akmali, M. Berberine Attenuated Oxidative Stress Induced by Sodium Nitrite in Rat Liver. Jundishapur Journal of Natural Pharmaceutical Products. 2019, 14(1), e68532. DOI: 10.5812/jjnpp.68532.
  • Zhu, X.; Guo, X.; Mao, G.; Gao, Z.; Wang, H.; He, Q.; Li, D. Hepatoprotection of Berberine against Hydrogen Peroxide-induced Apoptosis by Upregulation of Sirtuin 1. Phytotherapy Res. 2013, 27(3), 417–421. DOI: 10.1002/ptr.4728.
  • Zhao, H.; Halicka, H. D.; Li, J.; Darzynkiewicz, Z. Berberine Suppresses gero-conversion from Cell Cycle Arrest to Senescence. Aging (Albany NY). 2013, 5(8), 623. DOI: 10.18632/aging.100593.
  • Dai, P.; Wang, J.; Lin, L.; Zhang, Y.; Wang, Z. Renoprotective Effects of Berberine as Adjuvant Therapy for Hypertensive Patients with Type 2 Diabetes Mellitus: Evaluation via Biochemical Markers and Color Doppler Ultrasonography. Exp. Ther. Med. 2015, 10(3), 869–876. DOI: 10.3892/etm.2015.2585.
  • Othman, M. S.; Safwat, G.; Aboulkhair, M.; Abdel Moneim, A. E. The Potential Effect of Berberine in mercury-induced Hepatorenal Toxicity in Albino Rats. Food Chem. Toxicol. 2014, 69, 175–181. DOI: 10.1016/j.fct.2014.04.012.
  • Domitrović, R.; Cvijanović, O.; Pernjak-Pugel, E.; Škoda, M.; Mikelić, L.; Crnčević-Orlić, Ž. Berberine Exerts Nephroprotective Effect against cisplatin-induced Kidney Damage through Inhibition of oxidative/nitrosative Stress, Inflammation, Autophagy and Apoptosis. Food Chem. Toxicol. 2013, 62, 397–406. DOI: 10.1016/j.fct.2013.09.003.
  • Najaran, H.; Bafrani, H. H.; Rashtbari, H.; Izadpanah, F.; Rajabi, M. R.; Kashani, H. H.; Mohammadi, A. Evaluation of the Serum Sex Hormones Levels and Alkaline Phosphatase Activity in Rats’ Testis after Administering of Berberine in Experimental Varicocele. Oriental Pharmacy and Experi. Med. 2019, 19, 157–165. DOI: 10.1007/s13596-019-00369-x.